// /lib/drug-config.ts

// 4-Stage Metabolic Bridge êµ¬ê°„ ì •ì˜
export const STAGES = [
  { phase: 'adaptation', name: 'ì ì‘ê¸°', icon: 'ğŸ’§', start: 0, end: 4.9, color: '#3B82F6', msg: "ë§ì€ ë¶„ë“¤ì´ ì´ ì‹œê¸°ì— ì¶©ë¶„í•œ ìˆ˜ë¶„ ì„­ì·¨ê°€ ëª¸ì˜ ì ì‘ì„ ë•ëŠ”ë‹¤ê³  ëŠë‚ë‹ˆë‹¤." },
  { phase: 'loss', name: 'ê°ëŸ‰ê¸°', icon: 'ğŸ”¥', start: 5, end: 16.9, color: '#10B981', msg: "ì´ ì‹œì ì—ì„œëŠ” ì²´ì§€ë°© ìœ„ì£¼ì˜ ê°ëŸ‰ì„ í™•ì¸í•˜ëŠ” ê²ƒì´ ì„±ì·¨ê°ì„ ë†’ì´ëŠ” ë° íš¨ê³¼ì ì…ë‹ˆë‹¤." },
  { phase: 'bridge', name: 'ê°€êµê¸°', icon: 'ğŸŒ‰', start: 17, end: 36.9, color: '#F59E0B', msg: "ë§ì€ ì‚¬ëŒë“¤ì´ ì´ ë‹¨ê³„ì—ì„œ ê·¼ì†ì‹¤ ê´€ë¦¬ê°€ í–¥í›„ ìœ ì§€ì˜ í•µì‹¬ì„ì„ ì¸ì§€í•˜ê¸° ì‹œì‘í•©ë‹ˆë‹¤." },
  { phase: 'maintenance', name: 'ìœ ì§€ê¸°', icon: 'ğŸ›¡ï¸', start: 37, end: 72, color: '#8B5CF6', msg: "ì´ì œëŠ” ìŠ¤ìŠ¤ë¡œì˜ ë£¨í‹´ë§Œìœ¼ë¡œë„ ê±´ê°•í•œ ëŒ€ì‚¬ ì²´ê³„ê°€ ìœ ì§€ëœë‹¤ëŠ” í™•ì‹ ì„ ê°–ê²Œ ë˜ëŠ” ì‹œê¸°ì…ë‹ˆë‹¤." }
];

export const CLINICAL_DATA = {
  WEGOVY: {
    name: "Wegovy", // STEP-1 trial (NEJM 2021)
    weeks: [0, 4, 8, 12, 20, 36, 52, 72],
    values: [0, -2.2, -4.0, -6.0, -9.4, -13.3, -15.4, -16.0]
  },
  MOUNJARO: {
    name: "Tirzepatide", // SURMOUNT-1 (NEJM 2022)
    weeks: [0, 4, 8, 12, 20, 36, 52, 72],
    dose: {
      "15mg": [0, -3.8, -7.0, -9.0, -12.0, -19.0, -21.5, -22.5]
    }
  }
};

export const DRUG_TYPES = {
  MOUNJARO: { name: "í„°ì œíƒ€íŒŒì´ë“œ", steps: [2.5, 5, 7.5, 10, 12.5, 15], unit: "mg" },
  WEGOVY: { name: "ìœ„ê³ ë¹„", steps: [0.25, 0.5, 1.0, 1.7, 2.4], unit: "mg" }
};
